HIGHLIGHTS
- Who: Prostate cancer et al. from the Faculty of Science, The University of Sydney, Sydney, Australia have published the research: Small-Molecule Drugs target Androgen Receptor (AR) signaling pathway for Prostatic Cancer Treatment, in the : Proceedings of ICBioMed 2024 Workshop: Computational Proteomics in Drug Discovery and Development from Medicinal Plants of April/28,/2009
- Future: Future studies should concentrate on creating new targeted approaches to overcome resistance to existing therapies and further improve patient outcomes.
SUMMARY
That elevated Gleason scores correspond with diminished GnRH-R expression levels, which is associated with . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.